Company Description
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use.
It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells.
In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions.
It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
| Country | United States |
| Founded | 1989 |
| IPO Date | Jan 21, 1997 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 76 |
| CEO | David I. Portnoy |
Contact Details
Address: 700 Brooker Creek Boulevard, Suite 1800 Oldsmar, Florida 34677 United States | |
| Phone | 813 749 2100 |
| Website | cryo-cell.com |
Stock Details
| Ticker Symbol | CCEL |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | December - November |
| Reporting Currency | USD |
| CIK Code | 0000862692 |
| CUSIP Number | 228895108 |
| ISIN Number | US2288951088 |
| Employer ID | 22-3023093 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Mark L. Portnoy | Co-Chief Executive Officer and Director |
| David I. Portnoy | Chairman and Co-Chief Executive Officer |
| Jill M. Taymans | Chief Financial Officer and Vice President of Finance |
| Oleg Mikulinsky | Chief Information Officer |
| Dr. Joanne Kurtzberg M.D. | Medical Director and Member of Medical and Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 12, 2026 | 8-K | Current Report |
| Feb 27, 2026 | 10-K | Annual Report |
| Nov 12, 2025 | 8-K | Current Report |
| Oct 23, 2025 | 8-K | Current Report |
| Oct 15, 2025 | 10-Q | Quarterly Report |
| Sep 26, 2025 | DEF 14A | Other definitive proxy statements |
| Sep 26, 2025 | ARS | Filing |
| Sep 10, 2025 | 8-K | Current Report |
| Jul 15, 2025 | 10-Q | Quarterly Report |
| May 22, 2025 | 8-K | Current Report |